Overview
What is Retatrutide?
Retatrutide's triple-agonist mechanism simultaneously targets GLP-1R (appetite, insulin), GIPR (incretin enhancement, fat metabolism), and GCGR (energy expenditure, hepatic glucose output). The GCGR component distinguishes it from semaglutide and tirzepatide, theoretically increasing energy expenditure in addition to reducing caloric intake — a potentially additive mechanism not seen in dual agonists.
Phase 2 trial data reported substantial weight reduction at higher doses over 48 weeks. The compound is still in clinical development with no pharmaceutical formulation currently available. Research protocols are extrapolated from available trial data. Careful dose titration over many months is essential.
🧠GLP-1 Agonism
Reduces appetite via hypothalamic signalling and improves pancreatic insulin secretion.
⚡GIP Agonism
Enhances incretin activity and may improve lipid metabolism and adipose tissue function.
🔥GCGR Agonism
Increases hepatic glucose output and energy expenditure — mechanism unique to triple agonists.
📊Additive Effects
Triple receptor activation may produce metabolic effects greater than achievable with dual agonists.
Reconstitution
Reconstitution Calculator
Enter your vial size and BAC water volume to calculate your exact concentration, syringe units, and number of doses per vial.
Interactive Calculator
Dose Planner for Retatrutide
Loading…
Step-by-step
How to reconstitute
1
Gather supplies
Lyophilised peptide vial, bacteriostatic water, a drawing syringe (1–3 mL), U-100 insulin syringes for dosing, and alcohol swabs. Work on a clean surface.
2
Swab and dry
Wipe stoppers on both vials with alcohol swabs. Wait 10–15 seconds for full evaporation before piercing. Never blow or touch after swabbing.
3
Add BAC water slowly
Draw BAC water into your syringe, insert into peptide vial, and inject slowly down the inside glass wall — never directly onto the powder cake.
4
Swirl gently — do not shake
Roll the vial between your palms until powder fully dissolves. Solution should be clear and colourless. Shaking degrades the peptide.
💡 If still cloudy after 2 minutes, gently swirl again and wait. Discard if permanent cloudiness or particulates appear.
5
Label and refrigerate
Label with compound name, concentration, and reconstitution date. Store at 2–8 °C. Most reconstituted peptides are stable for 4–6 weeks refrigerated.
Dosing Protocol
Dosing Schedule
Research-derived dosing ranges. Always begin conservatively to assess tolerance.
| Phase | Dose | Frequency | Duration | Notes |
|---|
| Start | 1 mg | Once weekly | Weeks 1–4 | Minimum tolerated dose. GI side effects most likely here. |
| Titrate | 2 mg | Once weekly | Weeks 5–8 | Increase every 4 weeks as tolerated. |
| Working dose | 4–8 mg | Once weekly | Weeks 9–24 | Range studied in Phase 2/3 trials. |
| High dose | 10–12 mg | Once weekly | Week 24+ | Highest doses from trial data. Advance only if prior stages well tolerated. |
🌶️
Use the PepperCalc calculatorEnter your exact vial size and BAC water above to get your precise syringe units for each dose. No guesswork.
Administration
Injection Sites
🫃
Abdomen
Lower abdominal subcutaneous fat. Standard GLP-1 class injection site.
🦵
Thigh
Outer thigh subcutaneous fat. Consistent absorption.
🔄
Weekly Rotation
Rotate sites weekly to prevent localised lipohypertrophy.
Safety Profile
Safety & Side Effects
✓ Generally Well Tolerated
Once-weekly dosing
Novel triple mechanism under active clinical investigation
No androgenic activity
Promising Phase 2/3 data
⚠ Potential Concerns
Significant GI effects during titration (nausea, vomiting)
No approved pharmaceutical formulation
Limited long-term safety data vs semaglutide
Requires very slow titration protocol
⚠️
Research use onlyThis page is an educational reference. None of this constitutes medical advice. Consult a qualified professional before any use. All compounds are for research purposes only.
Recommended Source
Source your compounds at White Market Peptides
Use code PEPDOSE for 10% off + free 2-day shipping over $200
Shop Now →